INS and coronary artery disorder: Patients who used both insulin and OAD (16.8%, 95% CI 12.5 ~ 21.1%) had higher 10-year risk of nonfatal (P = 0.025) CHD, compared to those under OAD monotherapy (11.8%, 95% CI 10.6 ~ 13.0%).